Implementation outcomes
ADVERSE EVENTS
Descriptive statistics will be analyzed for all pre-defined implementation outcomes, including reach, clinical effectiveness, system-level adoption, implementation, and maintenance. Exploratory bivariate analyses will also look for key sources of variation as they relate to the prescriber or patient characteristics, especially those identified as potential moderators. We will also repeat aims 1 and 2 analyses with clinical effectiveness (including adverse events) and implementation fidelity outcomes to assess whether there are any statistically or clinically significant differences across alert or notification types for any outcomes.Additional details about additional exploratory analyses, the handling of missing data, sensitivity analyses are included in the 